CardiAQ Valve Technologies
First-in-class minimally invasive device for mitral heart valve replacement
CardiAQ Valve Technologies (CVT) has developed trans-apical and trans-femoral systems as minimally invasive alternatives to open heart surgery for mitral valve repair and replacement.
Early clinical data has shown that the CVT system improves heart pumping efficiency just as well as on open heart surgery, so improving outcome and recovery time.
CEO Rob Michiels